Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00058864 · ClinicalTrials.gov registry record · NA
The HIP Impact Protection Program (HIP PRO)
A NA study of Hip Fractures, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- NA
- Development phase
- 546
- Enrollment target
- 4
- Study locations
NCT00058864: Completed NA study of Hip Fractures, sponsored by National Institute on Aging (NIA).
NCT00058864 is a NA study of Hip Fractures that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 546 participants, roughly in line with the 585-participant average among 15 other Hip Fractures trials with a reported enrollment target. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00058864, a NA study of Hip Fractures, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- NA
- Development phase
- 546 participants
- Enrollment target
- 4
- Study locations
Study Summary
HIP PRO is a multicenter randomized, controlled trial of an energy absorbing and distributing padding system designed to reduce the incidence of hip fractures in 546 nursing home (NH) residents. The trial is being conducted in three geographic regions of the US: Boston, St. Louis, and Baltimore. Non bed- or chair-bound residents over the age of 65 are given protective underwear containing a single pocket and hip pad so that each resident becomes his/her own control. During the trial, hip fracture incidence will be compared in padded and unpadded hips using an intent to treat analysis. A secondary aim is to identify resident and facility factors contributing to non-adherence with the use of the hip protector.
Conditions Studied
Interventions
- DEVICE Energy absorbing and distributing trochanteric pad
Study Locations (4)
Maryland
- University of Maryland, Baltimore - Baltimore
- Maryland Medical Research Institute - Baltimore
Massachusetts
- Hebrew Rehabilitation Center for Aged Research and Training Institute - Boston
Missouri
- Washington University School of Medicine, Division of Geriatrics & Gerontology - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2001-09 |
| Est. Completion | 2006-08 |
| Phase | NA |
What the finished NCT00058864 record still lists
NCT00058864 is an interventional study that assigns participants to a tested intervention. The registered 546 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 585-participant average among 15 other Hip Fractures trials with a reported enrollment target.
The record links to 1 condition, with Hip Fractures appearing as the primary indexed condition, and to 1 intervention - of which Energy absorbing and distributing trochanteric pad is the first listed.
NCT00058864 reports a single indexed study location in Maryland, Massachusetts, Missouri.
Frequently Asked Questions
What is clinical trial NCT00058864 about?
NCT00058864 is a clinical study titled "The HIP Impact Protection Program (HIP PRO)". HIP PRO is a multicenter randomized, controlled trial of an energy absorbing and distributing padding system designed to reduce the incidence of hip fractures in 546 nursing home (NH) residents. The trial is being conducted in three geographic regions of the US: Boston, St. Louis, and Baltimore. Non...
What is the current status of trial NCT00058864?
This trial is currently completed. It is a NA study. The enrollment target is 546 participants. The study started on 2001-09. Estimated completion is 2006-08.
What conditions does trial NCT00058864 study?
This clinical trial studies the following conditions: Hip Fractures.
What interventions are being tested in trial NCT00058864?
The interventions under investigation include: Energy absorbing and distributing trochanteric pad (DEVICE).
Who is sponsoring clinical trial NCT00058864?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00058864 being conducted?
This trial has 4 study locations across Maryland, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00058864's enrollment target sits among peer trials
546 6th of 15 higher than 10 of 15 other Hip Fractures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hip Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
RECRUITING · NA
-
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
RECRUITING · NA
-
Cervical Myelopathy in Hip Fracture Patients
RECRUITING · NA
-
PENG vs Femoral Block for Hip Fracture Analgesia
RECRUITING · NA
-
Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation
RECRUITING · NA
-
The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03572374 · 546 participants · NA
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
- NCT05937685 · 546 participants · NA
Reducing Blood Pressure in Patients With High Cardiovascular Risk
- NCT06416150 · 546 participants · NA
Reducing Urban Cervical Cancer Disparities
- NCT06850922 · 546 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia